Metintaş, M. Et Al. 2023. BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to chemotherapy in patients with malignant pleural mesothelioma. iMig 2023 , (Lille, France), 1-2.

Metintaş, M., Yüce, T., Ak, G., Dündar, E., Panou, V., Roe, O. D., ... Metintaş, S.(2023). BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to chemotherapy in patients with malignant pleural mesothelioma . iMig 2023 (pp.1-2). Lille, France

Metintaş, MUZAFFER Et Al. "BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to chemotherapy in patients with malignant pleural mesothelioma," iMig 2023, Lille, France, 2023

Metintaş, MUZAFFER Et Al. "BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to chemotherapy in patients with malignant pleural mesothelioma." iMig 2023 , Lille, France, pp.1-2, 2023

Metintaş, M. Et Al. (2023) . "BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to chemotherapy in patients with malignant pleural mesothelioma." iMig 2023 , Lille, France, pp.1-2.

@conferencepaper{conferencepaper, author={MUZAFFER METİNTAŞ Et Al. }, title={BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to chemotherapy in patients with malignant pleural mesothelioma}, congress name={iMig 2023}, city={Lille}, country={France}, year={2023}, pages={1-2} }